Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Opinion meeting with the PAAB
-
Hello,
We would like to schedule an opinion meeting with the PAAB to discuss one of our digital initiatives. I understand from the PAAB site that there is a fee and is arranged by emailing P. Massad. Can you please confirm this is the process and are we limited to number of attendees from Pharma company.
-
Hey @SKW
As Patrick Massad is now the Commissioner, you should reach out to Yin Man, Senior Reviewer of Preclearance, to request opinion meetings. We have updated the website accordingly. Additionally, you are not restricted to the number of attendees from the Pharma company.
Thank you for the questions.
